Biblio

10 resultats trouvés
Filtres: Auteur is Laguerre, B.  [Clear All Filters]
A
Derosa L., C. Silva ACosta, Dalban C., Colomba E., Negrier S., Chevreau C.M, Gravis G., Oudard S.M, Laguerre B., Barthelemy P. et al..  2021.  Antibiotic (ATB) therapy and outcome from nivolumab (N) in metastatic renal cell carcinoma (mRCC) patients (pts): Results of the GETUG-AFU 26 NIVOREN multicentric phase II study. ANNALS OF ONCOLOGY. 32:S681.
B
Flippot R., Dalban C., Laguerre B., Borchiellini D., Gravis G., Negrier S., Chevreau C.M, Joly F., Geoffrois L., Ladoire S. et al..  2018.  Brain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial. ANNALS OF ONCOLOGY. 29:306.
Flippot R., Dalban C., Laguerre B., Borchiellini D., Gravis G., Negrier S., Chevreau C.M, Joly F., Geoffrois L., Ladoire S. et al..  2018.  Brain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial. ANNALS OF ONCOLOGY. 29:306.
C
Gross-Goupil M., Flechon A., Mourey L., Topart D., Gravis G., Oudard S., Tourani J.M, Geoffrois L., Meriaux E., Thiery-Vuillemin A. et al..  2020.  Cabozantinib in elderly patients: Results from a subanalysis of the CABOREAL study. ANNALS OF ONCOLOGY. 31:S566-S567.
Flechon A., Chevreau C.M, Topart D., Gravis G., Oudard S., Tourani J.M, Geoffrois L., Meriaux E., Thiery-Vuillemin A., Barthelemy P. et al..  2020.  Cabozantinib in non-clear cell metastatic renal cell carcinoma and sarcomatoid renal cell carcinoma: Real-world data from the CABOREAL study. ANNALS OF ONCOLOGY. 31:S572-S573.
F
Ravaud A., Oudard S., De Fromont M., Chevreau C., Gravis G., Zanetta S., Theodore C., Jimenez M., Sevin E., Laguerre B. et al..  2015.  First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG). ANNALS OF ONCOLOGY. 26:1123-1128.
I
Lefort F., Dalban C., Gross-Goupil M., Laguerre B., Barthelemy P., Sarradin V., Chanez B., Negrier S., Geoffrois L., Gillon P. et al..  2019.  Impact of corticosteroids on nivolumab activity in metastatic clear cell renal cell carcinoma. ANNALS OF ONCOLOGY. 30:391.
P
Guigay J., Bidault F., Fayette J., Even C., Cupissol D., Rolland F., Peyrade F., Laguerre B., Le Tourneau C., Zanetta S. et al..  2016.  Pazopanib in patients with progressive recurrent or metastatic (R/M) salivary gland carcinoma (SGC): Further evaluation of efficacy including tumor growth rates (GR) analysis. H&N Unicancer Group PACSA trial with the REFCOR. ANNALS OF ONCOLOGY. 27
Courcier J., Dalban C., Laguerre B., Ladoire S., Barthelemy P., Oudard S., Joly F., G. Mescam G, Chevreau C.M, Geoffrois L. et al..  2020.  Primary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial. ANNALS OF ONCOLOGY. 31:S560.
S
Mejean A., Ravaud A., Thezenas S., Colas S., Beauval J.-B, Bensalah K., Geoffrois L., Thiery-Vuillemin A., Cormier L., Lang H. et al..  2018.  Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma. NEW ENGLAND JOURNAL OF MEDICINE. 379:417-427.